Ajaz Hussain

fda qbd pat quality assurance quality us fda quality by design pharmaceuticals pharmaceutical cgmp professional development gmp development biosimilars system design maturity india culture cmc generics therapeutic equivalence systems thinking data integrity risk nipte professional qms ich q10 validation fda cder voice of patients ich q8 continued process verificaiton usa continulal professional development data integrity order of conciousness behavior 21st century cures act bioequivalence quality control generic drugs warning letters good experience process placebo science pharmaceutical equivalence inspection evidence ema import alert office of pharmaceutical quality chaos real world complexity conciousness complex adult human develoment continuous improvement continuous manufactruing manufacturing dissolution smart practices form 483 compliance internal validation control substitution industry 4.0 regulatory science excipients ich q9 uncertainty patients confidence systems usp interchangeability self-authored practice ai expectation statistical technology vaccine fda qbd gmp cmc review inspection metrics design r irrational management leadership external validaiton equivalence affordability assurance biotechnology pharmaceutical technology managment human nocebo experience economy user experience behavioral economics orders of conciousness pharmaceutical engineering hussain warning letter breaches cheating big data value china quality management system knowledge managment education and training design thinking biases pharmacy pharmaceutical industry industry nist ich methylphenidate education engineering adhd capa regulation pharma 4.0 review certification bcs one quality voice expereince economy similarity regulatory uncertainty blind-spots personalized nda cognitive by desing medicine anda eu comparability thinking pay for performacne understanding concerta regulations gcp adhearance glp continual improvment professionaljourney cost of drugs supply chain manufactruing usa insight culture of pharmaceutical quality uncertinty ajaz llm regualtion q10 formulation sciences subject by formulation drug regulation emotions response generic oos pharmacist invalidated oos rate cmc review ajaz hussain training expereince knowledge regulatory communication question based development safety voice knowledge management community of knowledge pat cppr nipte desing sameness new prior knowledge statistics satisfaction fractals drug shortages efficacy nanotechnology recalls errors measurement calibrator therapeutic capability common cause challenges quantity process validaiton risk management inspections matruity qualia controls patient safety customer experience continuous inequality university devices 2014 innovation drug discovery generic< medicine quality-by-design next generation educating drugs target failure factors preventive pragmatic implementation blind thniking organizational communication row integrative logic careing reliability intention attitude drug utilisation risk managment gauge r&r pharmacopoeias epa profile pharmacokinetics and pharmacodynamics amos tversky poor norms consciously fdasia breakthrough therapy designation counterfeits behaviour opportunities integrative thinking argumentation economics heparin complinace haikudeck complaints tablet habits testing system. pharmacokinetics keystone pharmaceutics perception opq specifications fraud malaria subconscious fear daniel kahneman econometric interchangeeability tablets replicate trial and error interaction q11 econometrics q12 q8 q9 predictive pat team chemometrics food & drug administration biowaiver oration pharmacometrics attention deficit patient team cluster collaboration ab rating real time release cancer lack of effect disorder classification biosimilar biopharmaceutics biomarkers mechanistic exposure panjab #good #gmp #glp #gcp #maturity #development #suitability #capability #regualtion #control #lifecycle #lifespiral #laws #orders #self-authership #quality #assurance evil immaturity post-truth aloca law mandates cognative interest audit adulthood repurposing weight of evidence totality of evidence residual uncertainty r malcom baldridge award qulaity new drugs aaps cphi 2020 orders of consciousness doe faculty best practices 21st century ich 14 supac professional journey borg emergent smartphones smartfactory sustainability good practices #validaiton #practices desing expected intelligence artifical natural meanning common sense fd&c act regualtions human 4.0 ml formulation profession matrutity observations warning lettr cpv life-cycle chatgpt remediaiton inactive ingredients formulaiton self-correcting new prior knowldge inactive ingredients deviations failures conciousess validaiton pharma 4 industry 4 revolution mangement dscsa serialization generic drug theraputic resilience intution instiution regulator sfda concionsness care health pharmacy to the world change management monoclonal antibodies fda thai streamline advanced analytics charecterization shepherding continual improvement angle of repose six blind men and the elephant rumi snakes and ladders bioequivalence generic nasal sprary crtitical path niimbl president-elect transformation trump quality of drugs ajaz s. hussain advice part 11 software makeing in america globalization process analytical technology email marketing interchnageability happiness selfconfidence socialized mind real-time controls metrics badi quaity equivance eurpoe pharma 483 violations emerging economies canada health canada price pressure epistemic trust gdufa qbr integrated six sigma passion persistance who mhra defaults bla patheon qbd. 21st century cmo tipping point elephant in the dark alcoa theraputic equivalence ifpac excipientes certificaiton information technology wisdom pqri personal harm reduction vaping smoking mrtp clinical trials leadership development ich q12 ich q11 inactive ingredient guide constructive development theory quality system omission comission special cause suitability contol consciousness pharmaceutical engineering science covid19 adpharming msc industrial engineering branding biotech chemical emotional inteligence adult development deming theory of knowledge epistemology product withdrawals import alerts process validation availability comlexity one voice ecology efficiency income outcome lifecycle rumination emotional processing levothyroxine brand drugs theraputics